These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 37236245)
21. Kisspeptin levels in relation to sex hormone profile among PCOS patients. Zarei E; Binabaj MM; Zadeh FM; Bakhshandeh Nosrat S; Veghari G; Mansourian A Ir J Med Sci; 2022 Aug; 191(4):1711-1716. PubMed ID: 34378162 [TBL] [Abstract][Full Text] [Related]
22. Circulating anti-Müllerian hormone levels in relation to nutritional status and selected adipokines levels in polycystic ovary syndrome. Olszanecka-Glinianowicz M; Madej P; Owczarek A; Chudek J; Skałba P Clin Endocrinol (Oxf); 2015 Jul; 83(1):98-104. PubMed ID: 25440474 [TBL] [Abstract][Full Text] [Related]
23. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome. Sahmay S; Atakul N; Aydogan B; Aydin Y; Imamoglu M; Seyisoglu H Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1369-74. PubMed ID: 23980726 [TBL] [Abstract][Full Text] [Related]
24. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome. Baranowska B; Radzikowska M; Wasilewska-Dziubińska E; Kapliński A; Roguski K; Płonowski A Gynecol Endocrinol; 1999 Oct; 13(5):344-51. PubMed ID: 10599552 [TBL] [Abstract][Full Text] [Related]
25. Relationship between body composition, insulin resistance, and hormonal profiles in women with polycystic ovary syndrome. Zhang H; Wang W; Zhao J; Jiao P; Zeng L; Zhang H; Zhao Y; Shi L; Hu H; Luo L; Fukuzawa I; Li D; Li R; Qiao J Front Endocrinol (Lausanne); 2022; 13():1085656. PubMed ID: 36699018 [TBL] [Abstract][Full Text] [Related]
26. Serum Kisspeptin levels in unexplained infertility, polycystic ovary syndrome, and male factor infertility. Kaya C; Alay İ; Babayeva G; Gedikbaşı A; Ertaş Kaya S; Ekin M; Yaşar L Gynecol Endocrinol; 2019 Mar; 35(3):228-232. PubMed ID: 30328739 [TBL] [Abstract][Full Text] [Related]
27. Kisspeptin and body weight homeostasis in relation to phenotypic features of polycystic ovary syndrome; metabolic regulation of reproduction. Rashad NM; Al-Sayed RM; Yousef MS; Saraya YS Diabetes Metab Syndr; 2019; 13(3):2086-2092. PubMed ID: 31235141 [TBL] [Abstract][Full Text] [Related]
29. Follicle Stimulating Hormone (LH: FSH) Ratio in Polycystic Ovary Syndrome (PCOS) - Obese vs. Non- Obese Women. Saadia Z Med Arch; 2020 Aug; 74(4):289-293. PubMed ID: 33041447 [TBL] [Abstract][Full Text] [Related]
30. Differences of the association of anti-Müllerian hormone with clinical or biochemical characteristics between women with and without polycystic ovary syndrome. Woo HY; Kim KH; Rhee EJ; Park H; Lee MK Endocr J; 2012; 59(9):781-90. PubMed ID: 22673409 [TBL] [Abstract][Full Text] [Related]
31. Association of lipid profile and obesity in patients with polycystic ovary syndrome. Parveen S; Khan S; Khan MM; Gupta B; Ahmad A; Alam R Endocr Regul; 2024 Jan; 58(1):83-90. PubMed ID: 38656255 [No Abstract] [Full Text] [Related]
32. Mechanism of elevated LH/FSH ratio in lean PCOS revisited: a path analysis. Pratama G; Wiweko B; Asmarinah ; Widyahening IS; Andraini T; Bayuaji H; Hestiantoro A Sci Rep; 2024 Apr; 14(1):8229. PubMed ID: 38589425 [TBL] [Abstract][Full Text] [Related]
33. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome. Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948 [TBL] [Abstract][Full Text] [Related]
34. Kisspeptin, leptin, and retinol-binding protein 4 in women with polycystic ovary syndrome. Jeon YE; Lee KE; Jung JA; Yim SY; Kim H; Seo SK; Cho S; Choi YS; Lee BS Gynecol Obstet Invest; 2013; 75(4):268-74. PubMed ID: 23571154 [TBL] [Abstract][Full Text] [Related]
35. Comparison of serum anti-Müllerian hormone levels in normal weight and overweight-obese adolescent patients with polycystic ovary syndrome. Cengiz H; Ekin M; Dagdeviren H; Yildiz Ş; Kaya C; Kanawati A Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():46-50. PubMed ID: 25036408 [TBL] [Abstract][Full Text] [Related]
36. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome. Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370 [TBL] [Abstract][Full Text] [Related]
37. Serum anti-Müllerian hormone concentration in women with polycystic ovary syndrome and type 1 diabetes mellitus. Łebkowska A; Adamska A; Karczewska-Kupczewska M; Nikołajuk A; Otziomek E; Milewski R; Górska M; Wołczyński S; Kowalska I Metabolism; 2016 May; 65(5):804-811. PubMed ID: 26961579 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of the Role of Ghrelin and Leptin as Biochemical Markers in Female with Polycystic Ovarian Syndrome. Ibrahim MK; Alobaidi AHA Antiinflamm Antiallergy Agents Med Chem; 2021; 20(4):373-379. PubMed ID: 33888052 [TBL] [Abstract][Full Text] [Related]
39. Clinical value of serum anti-mullerian hormone and inhibin B in prediction of ovarian response in patients with polycystic ovary syndrome. Zhang F; Liu XL; Rong N; Huang XW J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):70-73. PubMed ID: 28224431 [TBL] [Abstract][Full Text] [Related]
40. Prolactin Is Associated With Insulin Resistance and Beta-Cell Dysfunction in Infertile Women With Polycystic Ovary Syndrome. Yang H; Lin J; Li H; Liu Z; Chen X; Chen Q Front Endocrinol (Lausanne); 2021; 12():571229. PubMed ID: 33716958 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]